Florian Karl Kleinbeck

Title: Florian Karl Kleinbeck: Innovator in Pharmaceutical Chemistry

Introduction

Florian Karl Kleinbeck is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 3 patents, his work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents involves the invention of polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. This calcium salt is particularly useful in treating conditions that respond to the inhibition of neutral endopeptidases. Another significant patent focuses on the synthesis of 2-carboxamide cycloamino urea derivatives, providing processes and intermediate compounds that are essential for their preparation.

Career Highlights

Florian is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore and develop innovative solutions in the pharmaceutical industry. His contributions have been instrumental in advancing research and development in this field.

Collaborations

Throughout his career, Florian has collaborated with esteemed colleagues such as Bernhard Erb and Isabelle Sylvie Gallou. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Florian Karl Kleinbeck is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.